Objective This study aimed to evaluate the comparative clinical effectiveness and safety of
dexamethasone vs betamethasone for preterm birth. Data Sources The sources searched …

Background There is currently insufficient evidence on the safety and efficacy of antenatal
corticosteroids in preventing mortality and severe morbidity amongst late preterm newborns …

OBJECTIVE: To assess the incidence of short-term outcomes of low birth weight infants (≤
1,750 g) exposed prenatally to either dexamethasone or betamethasone. METHODS: We …

Background The safety and efficacy of antenatal glucocorticoids in women in low-resource
countries who are at risk for preterm birth are uncertain. Methods We conducted a …

Objectives The objective of this study was to use modern analysis and reporting methods to
present the full results of the first randomized trial of antenatal corticosteroids, performed 50 …

Importance Administration of corticosteroids to women at high risk for delivery in the late
preterm period (34-36 weeks' gestation) improves short-term neonatal outcomes. The cost …

Summary Background The WHO ACTION-I trial demonstrated that dexamethasone
significantly reduced neonatal mortality when administered to women at risk of early preterm …

Background Antenatal corticosteroids given to women before preterm birth improve infant
survival and health. However, whether dexamethasone or betamethasone have better …

Background Respiratory distress syndrome is a serious complication of prematurity causing
significant immediate and long‐term mortality and morbidity. Objectives The objective of this …

Background Antenatal corticosteroids (ACS) have long been regarded as a cornerstone
intervention in mitigating the adverse effects of a preterm birth. However, the safety and …